Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-21-005242

Options or other derivatives

  • Henn Matthew R. acquired 130,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Henn Matthew R.

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +130,000 130,000 D
Loading xslF345X03/doc4.xml…